Please enable Javascript on your browser for a better experience.
The Thyroid Panel Test measures Free T4 Index (T7), T3 Uptake, and Total T4 to evaluate thyroid hormone production and overall thyroid function. Abnormal results may indicate hypothyroidism, hyperthyroidism, or other endocrine disorders. Doctors use this test to investigate symptoms such as fatigue, weight changes, or irregular heartbeat and to monitor thyroid therapy. Results provide key insight into metabolism, energy balance, and endocrine health.
The Cardio IQ™ ASCVD Risk Panel with Score combines essential lipid testing, Total Cholesterol, HDL Cholesterol, Triglycerides, Non-HDL and calculated components, and Direct LDL, with ASCVD risk scores. Risk estimates incorporate key patient inputs including current smoking status, systolic blood pressure, diabetes status, and whether high blood pressure is being treated.
The Insulin Response to Glucose Test, 5 Specimens evaluates insulin secretion at fasting and multiple post-glucose solution intervals. This expanded assessment highlights beta-cell function, insulin sensitivity, and abnormalities in carbohydrate metabolism. Results offer valuable information on how the body clears glucose and help identify insulin resistance, metabolic dysfunction, and diabetes-related risks.
The TPO Antibody Endpoint Test measures thyroid peroxidase antibodies, which target the enzyme needed for thyroid hormone production. Elevated levels often indicate autoimmune thyroid disorders such as Hashimoto’s thyroiditis or Graves’ disease. Doctors use this test to confirm thyroid autoimmunity, investigate symptoms like fatigue or weight changes, and guide treatment planning for hypothyroidism, hyperthyroidism, or other thyroid-related conditions.